Qumata Group Ltd

Qumata Group Ltd specializes in advanced health assessment solutions, optimizing the underwriting processes for insurance providers through data analytics to enhance efficiency and risk management. Founded in 2017, Qumata Group Ltd operates from London, UK, and offers innovative health assessment solutions to insurance providers. The company has successfully closed six deals, the most recent being a Series A round on February 3, 2022, raising GBP 9 million led by MMC Ventures. Luca Schnettler, a co-founder, currently serves as CEO.

Qumata specializes in advanced health assessment solutions that streamline the underwriting process for insurance providers. Their core offerings focus on utilizing data analytics to identify the healthiest users for straight-through processing, thereby reducing the need for lengthy manual assessments. This service is particularly beneficial for insurance companies looking to mitigate health and anti-selection risks by leveraging data insights to inform their decisions. Qumata serves a diverse client base including insurers and financial institutions across various geographical markets, specifically targeting North America, Europe, and Asia-Pacific.

By enhancing the efficiency of underwriting processes, Qumata facilitates quicker and more accurate risk evaluations, ultimately improving customer satisfaction and operational efficiencies for their clients. Qumata's revenue model is grounded in subscription-based services tailored for insurance providers and financial institutions. Clients typically engage in multi-year contracts that allow access to Qumata's proprietary data analytics platform. Within this framework, transactions are structured around annual subscriptions that provide ongoing support and updates to their health assessment algorithms.

The company may also offer tiered pricing plans based on the volume of assessments processed and the depth of data analytics required. By focusing on partnerships with insurance firms, Qumata effectively positions itself as a trusted provider of vital health data insights, facilitating a seamless integration into existing underwriting practices. In February 2022, Qumata Group Ltd. raised GBP 9 million in Series A funding, which will support the company’s growth and expansion of operations across Asia and the UK.

The funding is part of a larger GBP 17 million Series A round. Qumata plans to enhance its product offerings and enter new markets, specifically targeting additional regions within Asia and further solidifying its presence in the UK.